These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12867414)

  • 1. Specific and potent inhibition of NAD+-dependent DNA ligase by pyridochromanones.
    Brötz-Oesterhelt H; Knezevic I; Bartel S; Lampe T; Warnecke-Eberz U; Ziegelbauer K; Häbich D; Labischinski H
    J Biol Chem; 2003 Oct; 278(41):39435-42. PubMed ID: 12867414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and functional characterization of an NAD(+)-dependent DNA ligase from Staphylococcus aureus.
    Kaczmarek FS; Zaniewski RP; Gootz TD; Danley DE; Mansour MN; Griffor M; Kamath AV; Cronan M; Mueller J; Sun D; Martin PK; Benton B; McDowell L; Biek D; Schmid MB
    J Bacteriol; 2001 May; 183(10):3016-24. PubMed ID: 11325928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD+-dependent DNA Ligase (Rv3014c) from Mycobacterium tuberculosis. Crystal structure of the adenylation domain and identification of novel inhibitors.
    Srivastava SK; Tripathi RP; Ramachandran R
    J Biol Chem; 2005 Aug; 280(34):30273-81. PubMed ID: 15901723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic dihydrobenzoxazepine and tetracyclic indole derivatives can specifically target bacterial DNA ligases and can distinguish them from human DNA ligase I.
    Yadav N; Khanam T; Shukla A; Rai N; Hajela K; Ramachandran R
    Org Biomol Chem; 2015 May; 13(19):5475-87. PubMed ID: 25875403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I.
    Srivastava SK; Dube D; Tewari N; Dwivedi N; Tripathi RP; Ramachandran R
    Nucleic Acids Res; 2005; 33(22):7090-101. PubMed ID: 16361267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel Inhibitors of
    Alomari A; Gowland R; Southwood C; Barrow J; Bentley Z; Calvin-Nelson J; Kaminski A; LeFevre M; Callaghan AJ; Vincent HA; Gowers DM
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.
    Srivastava SK; Dube D; Kukshal V; Jha AK; Hajela K; Ramachandran R
    Proteins; 2007 Oct; 69(1):97-111. PubMed ID: 17557328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of the eubacterial DNA ligase by arylamino compounds.
    Ciarrocchi G; MacPhee DG; Deady LW; Tilley L
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2766-72. PubMed ID: 10543760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD(+)-dependent DNA ligase: a novel target waiting for the right inhibitor.
    Dwivedi N; Dube D; Pandey J; Singh B; Kukshal V; Ramachandran R; Tripathi RP
    Med Res Rev; 2008 Jul; 28(4):545-68. PubMed ID: 18080330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-throughput assay for the adenylation reaction of bacterial DNA ligase.
    Miesel L; Kravec C; Xin AT; McMonagle P; Ma S; Pichardo J; Feld B; Barrabee E; Palermo R
    Anal Biochem; 2007 Jul; 366(1):9-17. PubMed ID: 17493575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward the virtual screening of potential drugs in the homology modeled NAD+ dependent DNA ligase from Mycobacterium tuberculosis.
    Singh V; Somvanshi P
    Protein Pept Lett; 2010 Feb; 17(2):269-76. PubMed ID: 20214650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening of specific chemical compounds by exploring E.coli NAD+-dependent DNA ligase as a target for antibacterial drug discovery.
    Akhoon BA; Gupta SK; Dhaliwal G; Srivastava M; Gupta SK
    J Mol Model; 2011 Feb; 17(2):265-73. PubMed ID: 20443037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinetic mechanism of S. pneumoniae DNA ligase and inhibition by adenosine-based antibacterial compounds.
    Jahić H; Liu CF; Thresher J; Livchak S; Wang H; Ehmann DE
    Biochem Pharmacol; 2012 Sep; 84(5):654-60. PubMed ID: 22743594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.
    Mills SD; Eakin AE; Buurman ET; Newman JV; Gao N; Huynh H; Johnson KD; Lahiri S; Shapiro AB; Walkup GK; Yang W; Stokes SS
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1088-96. PubMed ID: 21189350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second NAD(+)-dependent DNA ligase (LigB) in Escherichia coli.
    Sriskanda V; Shuman S
    Nucleic Acids Res; 2001 Dec; 29(24):4930-4. PubMed ID: 11812821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymes involved in DNA ligation and end-healing in the radioresistant bacterium Deinococcus radiodurans.
    Blasius M; Buob R; Shevelev IV; Hubscher U
    BMC Mol Biol; 2007 Aug; 8():69. PubMed ID: 17705817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Base-modified NAD and AMP derivatives and their activity against bacterial DNA ligases.
    Pergolizzi G; Cominetti MM; Butt JN; Field RA; Bowater RP; Wagner GK
    Org Biomol Chem; 2015 Jun; 13(22):6380-98. PubMed ID: 25974621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of an inhibitor specific to bacterial NAD+-dependent DNA ligases.
    Meier TI; Yan D; Peery RB; McAllister KA; Zook C; Peng SB; Zhao G
    FEBS J; 2008 Nov; 275(21):5258-71. PubMed ID: 18795946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA ligase from the psychrophile Pseudoalteromonas haloplanktis gives insights into the adaptation of proteins to low temperatures.
    Georlette D; Jónsson ZO; Van Petegem F; Chessa J; Van Beeumen J; Hübscher U; Gerday C
    Eur J Biochem; 2000 Jun; 267(12):3502-12. PubMed ID: 10848966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations.
    Murphy-Benenato K; Wang H; McGuire HM; Davis HE; Gao N; Prince DB; Jahic H; Stokes SS; Boriack-Sjodin PA
    Bioorg Med Chem Lett; 2014 Jan; 24(1):360-6. PubMed ID: 24287382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.